NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations:: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect

被引:203
作者
Nguyen, S
Dhedin, N
Vernant, JP
Kuentz, M
Al Jijakli, A
Rouas-Freiss, N
Carosella, ED
Boudifa, A
Debré, P
Vieillard, V
机构
[1] Hop La Pitie Salpetriere, INSERM, U543, Lab Immunol Cellulaire & Tissulaire, F-75013 Paris, France
[2] Hop La Pitie Salpetriere, Serv Hematol Clin, F-75013 Paris, France
[3] Hop Henri Mondor, Serv Hematol Clin, F-94010 Creteil, France
[4] Hop St Louis, CEA, Paris, France
关键词
D O I
10.1182/blood-2004-10-4113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Natural killer (NK) cell alloreactivity is reported to mediate strong GvL (graft versus leukemia) effect in patients after haploidentical stem-cell transplantation (SCT) for acute myeloid leukemia (AML). Because subsequent immune reconstitution remains a major concern, we studied NK-cell recovery in 10 patients with AML who received haplomismatched SC transplants, among whom no GvL effect was observed, despite the mismatched immunoglobulln-like receptor (KIR) ligand in the GvH direction for 8 of 10 patients. NK cells generated after SCT exhibited an immature phenotype: the cytotoxic CD3-CD56(dim) subset was small, expression of KIRs and NKp30 was reduced, while CD94/NKG2A expression was increased. This phenotype was associated to in vitro lower levels of cytotoxicity against a K562 cell line and against primary mismatched AML blasts than donor samples. This impaired lysis was correlated with CD94/NKG2A expression in NK cells. Blockading CD94/NKG2A restored lysis against the AML blasts, which all expressed HILA-E, the ligand for CD94/ NKG2A. Our present study allows a better understanding of the NK-cell differentiation after SCT. These results revealed that the NK cells generated after haplomismatched SCT are blocked at an immature state characterized by specific phenotypic features and impaired functioning, having potential impact for immune responsiveness and transplantation outcome. (c) 2005 by The American Society of Hematology.
引用
收藏
页码:4135 / 4142
页数:8
相关论文
共 45 条
[31]   Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants [J].
Ruggeri, L ;
Capanni, M ;
Urbani, E ;
Perruccio, K ;
Shlomchik, WD ;
Tosti, A ;
Posati, S ;
Rogaia, D ;
Frassoni, F ;
Aversa, F ;
Martelli, MF ;
Velardi, A .
SCIENCE, 2002, 295 (5562) :2097-2100
[32]   Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation [J].
Ruggeri, L ;
Capanni, M ;
Casucci, M ;
Volpi, I ;
Tosti, A ;
Perruccio, K ;
Urbani, E ;
Negrin, RS ;
Martelli, MF ;
Velardi, A .
BLOOD, 1999, 94 (01) :333-339
[33]  
Salcedo M, 1998, EUR J IMMUNOL, V28, P4356, DOI 10.1002/(SICI)1521-4141(199812)28:12<4356::AID-IMMU4356>3.0.CO
[34]  
2-H
[35]   Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device [J].
Schumm, M ;
Lang, P ;
Taylor, G ;
Kuçi, S ;
Klingebiel, T ;
Bühring, HJ ;
Geiselhart, A ;
Niethammer, D ;
Handgretinger, R .
JOURNAL OF HEMATOTHERAPY, 1999, 8 (02) :209-218
[36]   Genetic control of human NK cell repertoire [J].
Shilling, HG ;
Young, N ;
Guethlein, LA ;
Cheng, NW ;
Gardiner, CM ;
Tyan, D ;
Parham, P .
JOURNAL OF IMMUNOLOGY, 2002, 169 (01) :239-247
[37]   Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation [J].
Shilling, HG ;
McQueen, KL ;
Cheng, NW ;
Shizuru, JA ;
Negrin, RS ;
Parham, P .
BLOOD, 2003, 101 (09) :3730-3740
[38]   Early expression of triggering receptors and regulatory role of 2134 in human natural killer cell precursors undergoing in vitro differentiation [J].
Sivori, S ;
Falco, M ;
Marcenaro, E ;
Parolini, S ;
Biassoni, R ;
Bottino, C ;
Moretta, L ;
Moretta, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (07) :4526-4531
[39]   RETRACTED: TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver (Retracted Article) [J].
Takeda, K ;
Cretney, E ;
Hayakawa, Y ;
Ota, T ;
Akiba, H ;
Ogasawara, K ;
Yagita, H ;
Kinoshita, K ;
Okumura, K ;
Smyth, MJ .
BLOOD, 2005, 105 (05) :2082-2089
[40]  
Toomey JA, 1999, J IMMUNOL, V163, P3176